HOB Biotech Group (SHA:688656) subsidiary Hunan Haooubo Biopharmaceutical obtained four medical device registration certificates from Hunan province's food and drug administrator.

The approvals were for four diagnostic kits using magnetic particle chemiluminescence technology to test for antibodies related to melanoma differentiation-associated gene 5, gastric parietal cells, C1q and intrinsic factor, according to a Tuesday filing with the Shanghai bourse.

The registrations are valid until 2030.

Shares of the company rose 1% in recent trade.